NCT07517640 2026-04-08Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II TrialShanghai Pulmonary Hospital, Shanghai, ChinaPhase 2 Not yet recruiting45 enrolled